Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc
MEDXF
Primary Symbol:
T.MDP
Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA...
. Medexus Pharma Canada division is a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. The division’s prescription products include Metoject (Methotrexate Injection), Rupall (Rupatadine), Cuvposa (Glycopyrrolate Oral Solution), Pediapharm Naproxen Suspension (Naproxen) and others. Medexus Pharma USA division is a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States. The division’s products include Rasuvo, IXINITY and Gleolan.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Jul 20, 2021 10:56am
RE:Write up in Yahoo
Someone pays for these write ups and some are provided cheap stock prior to their release. Pay enough and you can have anything written you wish. Take them with a grain of salt, they are a dime
...more
(55)
•••
Boursicotte
X
View Profile
View Bullboard History
Comment by
Boursicotte
on Jul 19, 2021 4:20pm
RE:RE:RE:Doubled up
We launch coverage of Medexus Pharmaceuticals, Inc. with a Buy rating a $12.00/share price target.
Xcyte Digital Corp. Releases "Xperience" Subscription Service
posted May 17, 2024 9:00am by
Xcyte Digital Corp.
-
|
"Xcyte anticipates growing the Xperience one-stop offering further with additional event technologies and supporting services, such as digital marketing and lead generation. We look forward to providing future updates as we execute upon this growth strategy ...read more
(55)
•••
Boursicotte
X
View Profile
View Bullboard History
Comment by
Boursicotte
on Jul 19, 2021 4:16pm
RE:RE:Doubled up
YES. $ 12 US
(55)
•••
Boursicotte
X
View Profile
View Bullboard History
Comment by
Boursicotte
on Jul 19, 2021 4:14pm
RE:Doubled up
Medexus Pharmaceuticals Inc. | MEDXF - $6.15 - OTCQX | Buy Stock Data 52-Week Low - High Shares Out. (mil) Mkt. Cap.(mil) 3-Mo. Avg. Vol. 12-Mo.Price Target Cash (mil) Tot. Debt (mil) Year
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jul 14, 2021 4:49pm
News out 2 days ago
Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in Canada For those sitting on the Fence, August is fast approaching and the
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jul 09, 2021 10:25am
Doubled up
Can't believe the lack of post here. This stock is a flyer in Q3 and Q4. My previous post outlines how one analyst has Medexus as their #1 holding. Do you DD and find out why this one has a
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jul 05, 2021 2:57pm
Write up in Yahoo
Mon, July 5, 2021, 6:00 AM ·2 min read Medexus Pharmaceuticals (Vancouver: MDP) (OTC: MEDXF) — a Top Pick for 2021 — is the rare company that is cheap on its current
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jun 29, 2021 1:18pm
RE:Medexus gets Ok for Treosulfan in Canada
This is awesome news and should mean that the FDA approval is a done deal in August. Q4 (sept-dec) is going to be tremdous in terms of revenue.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jun 29, 2021 1:12pm
Medexus gets Ok for Treosulfan in Canada
https://www.globenewswire.com/news-release/2021/06/28/2254293/0/en/Medexus-Receives-Notice-of-Compliance-to-Commercialize-Treosulfan-in-Canada.html Ken d’Entremont, CEO, commented, “We are thrilled
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jun 24, 2021 10:16am
RE:RE:RE:Insider Buying!!!
Makes you wonder who they heck was selling. Load up if you can at this price because the next stop up could be $20.
(72)
•••
oceaneleven
X
View Profile
View Bullboard History
Comment by
oceaneleven
on Jun 23, 2021 4:31pm
RE:RE:Insider Buying!!!
not just 1 insider but 5 insiders buying!!!!! This horse is about to run!!!!
(72)
•••
oceaneleven
X
View Profile
View Bullboard History
Comment by
oceaneleven
on Jun 23, 2021 12:35pm
RE:Insider Buying!!!
https://www.canadianinsider.com/company?ticker=MDP
(72)
•••
oceaneleven
X
View Profile
View Bullboard History
Post by
oceaneleven
on Jun 23, 2021 12:32pm
Insider Buying!!!
https://www.canadianinsider.com/company?ticker=MDP
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jun 21, 2021 3:27pm
Gut check time... Nah!
Been here before and the selling is insane or shorts jumping in on the quarterlies. FDA approval is Aug 11, hopefully (not a certainty), then we are going higher.
(0)
•••
gjoseph22
X
View Profile
View Bullboard History
Comment by
gjoseph22
on Jun 17, 2021 3:28pm
RE:TIME ...
this is doing better than I thought would happen ... usually cost more on the TSX ... 6 weeks to August 11th is not that far away ...
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment